John Hussman's CRMD Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 315,000 shares of CorMedix Inc. (CRMD) worth $3.66 M, representing 0.79% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in CRMD, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 252,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's CorMedix (CRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CorMedix (CRMD) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +63,000 | New Buy | 63,000 | $12.32 |
| Q3 2025 | +252,000 | Add 400.00% | 315,000 | $11.63 |
John Hussman's CorMedix Investment FAQs
John Hussman first purchased CorMedix Inc. (CRMD) in Q2 2025, acquiring 63,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held CorMedix Inc. (CRMD) for 2 quarters since Q2 2025.
John Hussman's largest addition to CorMedix Inc. (CRMD) was in Q3 2025, adding 315,000 shares worth $3.66 M.
According to the latest 13F filing for Q3 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 315,000 shares of CorMedix Inc. (CRMD), valued at approximately $3.66 M.
As of the Q3 2025 filing, CorMedix Inc. (CRMD) represents approximately 0.79% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in CorMedix Inc. (CRMD) was 315,000 shares, as reported at the end of Q3 2025.